Do you support this bill?

Assembly Bill A1531A

2017-2018 Legislative Session

Relates to prescribing an opioid antagonist with a patient's first opioid analgesic prescription each year

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

Bill Amendments

co-Sponsors

multi-Sponsors

2017-A1531 - Details

See Senate Version of this Bill:
S5868
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §§3302 & 3309, Pub Health L
Versions Introduced in Other Legislative Sessions:
2013-2014: A9365
2015-2016: A661
2019-2020: S4095

2017-A1531 - Summary

Provides that every initial opioid analgesic prescription per year, which is equal to or greater than fifty morphine milligram equivalents, shall be accompanied with a prescription for an opioid antagonist.

2017-A1531 - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   1531
 
                        2017-2018 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 12, 2017
                                ___________
 
 Introduced  by  M.  of A. BRAUNSTEIN, DINOWITZ, OTIS, BRINDISI -- Multi-
   Sponsored by -- M. of  A.  McDONOUGH,  McLAUGHLIN  --  read  once  and
   referred to the Committee on Health
 
 AN  ACT  to  amend  the public health law, in relation to prescribing an
   opioid antagonist with a patient's first opioid analgesic prescription
   in a given year

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3302 of the public health law is amended by adding
 two new subdivisions 44 and 45 to read as follows:
   44. "OPIOID ANALGESICS" MEANS THE MEDICINES BUPRENOPHINE, BUTORPHANOL,
 CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE,
 MORPHINE, NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE,  PROPOXYPHENE
 AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
   45. "OPIOID ANTAGONIST" MEANS AN FDA-APPROVED DRUG THAT, WHEN ADMINIS-
 TERED,  NEGATES  OR  NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
 EFFECTS OF AN OPIOID IN THE BODY. THE OPIOID ANTAGONIST  IS  LIMITED  TO
 NALOXONE  OR  OTHER  MEDICATIONS  APPROVED  BY  THE  DEPARTMENT FOR THIS
 PURPOSE.
   § 2. Section 3309 of the public health law is amended by adding a  new
 subdivision 7 to read as follows:
   7.  EVERY  INITIAL  OPIOID  ANALGESIC  PRESCRIPTION  PER YEAR SHALL BE
 ACCOMPANIED WITH A PRESCRIPTION FOR AN OPIOID ANTAGONIST.
   § 3. This act shall take effect on the ninetieth day  after  it  shall
 have  become  a  law; provided, however, that effective immediately, the
 addition, amendment and/or repeal of any rule  or  regulation  necessary
 for  the implementation of this act on its effective date are authorized
 to be made and completed by the commissioner of health on or before such
 effective date.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD01695-01-7

co-Sponsors

multi-Sponsors

2017-A1531A (ACTIVE) - Details

See Senate Version of this Bill:
S5868
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §§3302 & 3309, Pub Health L
Versions Introduced in Other Legislative Sessions:
2013-2014: A9365
2015-2016: A661
2019-2020: S4095

2017-A1531A (ACTIVE) - Summary

Provides that every initial opioid analgesic prescription per year, which is equal to or greater than fifty morphine milligram equivalents, shall be accompanied with a prescription for an opioid antagonist.

2017-A1531A (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  1531--A
 
                        2017-2018 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             January 12, 2017
                                ___________
 
 Introduced  by  M.  of A. BRAUNSTEIN, DINOWITZ, OTIS, BRINDISI -- Multi-
   Sponsored by -- M. of A. McDONOUGH -- read once and  referred  to  the
   Committee  on  Health  --  recommitted  to  the Committee on Health in
   accordance with Assembly Rule 3, sec. 2 -- committee discharged,  bill
   amended,  ordered reprinted as amended and recommitted to said commit-
   tee
 
 AN ACT to amend the public health law, in  relation  to  prescribing  an
   opioid antagonist with a patient's first opioid analgesic prescription
   in a given year
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Section 3302 of the public health law is amended by  adding
 two new subdivisions 44 and 45 to read as follows:
   44. "OPIOID ANALGESICS" MEANS THE MEDICINES BUPRENOPHINE, BUTORPHANOL,
 CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE,
 MORPHINE,  NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE, PROPOXYPHENE
 AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
   45. "OPIOID ANTAGONIST" MEANS AN FDA-APPROVED DRUG THAT, WHEN ADMINIS-
 TERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN  PART  THE  PHARMACOLOGICAL
 EFFECTS  OF  AN  OPIOID IN THE BODY. THE OPIOID ANTAGONIST IS LIMITED TO
 NALOXONE OR OTHER  MEDICATIONS  APPROVED  BY  THE  DEPARTMENT  FOR  THIS
 PURPOSE.
   §  2. Section 3309 of the public health law is amended by adding a new
 subdivision 7 to read as follows:
   7. EVERY INITIAL OPIOID ANALGESIC  PRESCRIPTION  PER  YEAR,  WHICH  IS
 EQUAL  TO OR GREATER THAN FIFTY MORPHINE MILLIGRAM EQUIVALENTS, SHALL BE
 ACCOMPANIED WITH A PRESCRIPTION FOR AN OPIOID ANTAGONIST.
   § 3. This act shall take effect on the ninetieth day  after  it  shall
 have  become  a  law; provided, however, that effective immediately, the
 addition, amendment and/or repeal of any rule  or  regulation  necessary
 for  the implementation of this act on its effective date are authorized
 to be made and completed by the commissioner of health on or before such
 effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.